drugset / Trial / NCT05177939
Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To compare the efficacy and safety of NPB-01 in patients with autoimmune encephalitis refractory to steroid pulse therapy using steroid pulse therapy as a control.
Timeline
- Start
- 2022-03-03
- Primary completion
- 2024-05-31
- Completion
- 2024-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Immune Globulin Intravenous (Human) | Protein / enzyme biologic | — | — |
| Comparator | Methylprednisolone | Other / unclassified | — | — |